Kymriah
CAR T Rx Kymriah Gains Expanded Approval for Some Large B-Cell Lymphomas
The FDA has granted tisagenlecleucel (Kymriah, Novartis) its second indication—the treatment of adults with ...
MAY 4, 2018
FDA Approves Kymriah, First Gene Therapy in U.S.
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
AUGUST 31, 2017
Load more